Unsere Gruppe organisiert über 3000 globale Konferenzreihen Jährliche Veranstaltungen in den USA, Europa und anderen Ländern. Asien mit Unterstützung von 1000 weiteren wissenschaftlichen Gesellschaften und veröffentlicht über 700 Open Access Zeitschriften, die über 50.000 bedeutende Persönlichkeiten und renommierte Wissenschaftler als Redaktionsmitglieder enthalten.
Open-Access-Zeitschriften gewinnen mehr Leser und Zitierungen
700 Zeitschriften und 15.000.000 Leser Jede Zeitschrift erhält mehr als 25.000 Leser
Pramita Waghambare, Prabha Singh, Pramila Chaubey*
Colorectal cancer (CRC) is considered as the third most common cancer and the fourth foremost cause of death worldwide. Various
attempts have been made to diagnose and treat CRC. However, the incidence and mortality rates are still high. For CRC, currently available
chemotherapy delivers the drugs usually to both cancerous as well as normal cells, hence resulting in various undesirable side effects.
Therefore, nowadays more emphasis is been given on targeted drug delivery systems as it directly reaches to site of action with minimal
unwanted side effects. This review focuses on novel approaches for the treatment of CRC. Plant-derived drugs shows promising anticancer
activity and have various advantages over chemotherapeutics agents have also been explored. The current paper also elaborates on
synthetic drugs, plant-derived drugs and drugs targeting to overexpressed proteins in CRC including recent clinical trials in combinations
with other chemotherapeutics for the treatment of CRC.